T
TVA Medical
Medical device company developing innovative, minimally invasive therapies for the treatment of end stage renal disease
About TVA Medical
TVA Medical specializes in innovative medical devices for vascular access, particularly for patients with End Stage Kidney Disease (ESKD). The company's flagship product, the 4F EndoAVF System, offers a non-surgical alternative for creating arteriovenous (AV) fistulas, which are essential for hemodialysis. This system minimizes surgical scarring and arm disfigurement, providing multiple venous procedural approaches and additional anatomical AV fistula locations. TVA Medical primarily serves healthcare providers and patients requiring vascular access for dialysis. Operating in the medical device market, the company generates revenue through the sale of its proprietary EndoAVF systems and related accessories. The business model focuses on improving patient outcomes and reducing the complications associated with traditional surgical methods.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Dec 2016 | $7M | — | Square 1 Bank | — |
| SERIES C✓Equity / VC | Oct 2015 | $15M | $60M | Sante Ventures · S3 Ventures · Baxter Ventures · TriStar Health Partners | — |
Growth signals
Latest recorded traffic for TVA Medical is 230 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
TVA Medical in the Austin ecosystem
The TVA Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sante Ventures
S3 Ventures- TPTriStar Health Partners
Series B and later3 investors entered at this stage
Baxter Ventures
Boston Scientific
Square 1 Bank
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about TVA Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TVA Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









